Prodrugs of excitatory amino acids

Details Prodrugs of excitatory amino acids Prodrugs of excitatory amino acids

2003-06-06

2008-05-13

Wilson, James O. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07371872

ABSTRACT:
This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.

REFERENCES:
patent: 5688826 (1997-11-01), Massey et al.
patent: 5958960 (1999-09-01), Massey et al.
patent: 6316498 (2001-11-01), Nakazato et al.
patent: 6333428 (2001-12-01), Nakazato et al.
patent: 6716452 (2004-04-01), Piccariello et al.
patent: 6770676 (2004-08-01), Nakazato et al.
patent: WO 93/06127 (1993-04-01), None
patent: WO 98/04277 (1998-02-01), None
patent: WO 99/38839 (1999-08-01), None
patent: WO 00/12464 (2000-03-01), None
patent: WO 02/00605 (2002-01-01), None
patent: WO 02/34237 (2002-05-01), None
patent: WO 02/055481 (2002-07-01), None
patent: WO 02/055485 (2002-07-01), None
patent: WO 03/061698 (2003-07-01), None
patent: WO 03084610 (2003-10-01), None
patent: WO 03104217 (2003-12-01), None
Monn et al. Synthesis and Metabotropic Glutamate Receptor Activity of S-Oxidozed Variants of (−)-4-AMino-2-Thiabicyclo[3.1.0]hexane-4,6-dicarboxyalte: Identification of Potent, Selective, and Orally Bioavailable Agonists for mGlu2/3 Receptors. Journal of Medicinal Chemistry, 2007, 50, 233-240.
Bradshaw, T., et al., “Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles,”Molecular Cancer Therapeutics 1(4):239-246 (Feb. 2002).
Ohsumi, K., et al., “Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins,”Anti-Cancer Drug Design 14:539-548 (1999).
Sanchez, J. et al., “Quinolone anticbacterial agents. Synthesis and structure-actvitiy relationships of a series of amino acid prodrugs of racemic and chiral 7-(3-amino-1-pyrrolidinylquinolines, highly soluble quinolone prodrug with in vivo pseudomonas activity,”Journal of Medicinal Chemistry 35(10):1764-1773 (1992).
Yang, C.Y., et al., “Intestinal Peptide Transport Systems and Oral Drug Availability,”Pharmaceutical Research, 16(9):1331-1343 (1999).
Meredith, D., et al., “Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1,”Eur; J. Biochem, 267:3723-3728 (2000).
Sawada, K., et al., “Recognition ofL-Amino Acid Ester Compounds by Rat Peptide Transporters PEPT1 and PEPT2,”The Journal of Pharmacology and Experimental Therapeutics, 291(2):705 (1999).
Han, H-K., et al., “Designing Prodrugs for the HPEPT1 Transporter,”College of Pharmacy, The University of Michigan, p. 1259-260.
Dantzig, A.H., et al., “Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.”Biochimica et Biophysica Acta, 1027:211-217 (1990).
Han, H-K., “Targeted Prodrug Design to Optimize Drug Delivery,”AAPS Pharmsci, 2(1) article 6 (2000).

Affiliated with

Also associated with

Rating

Prodrugs of excitatory amino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prodrugs of excitatory amino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrugs of excitatory amino acids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3984548